(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013
18:04

Meta Introduces Palm-Sized Device to Use Muse AI
19:04

Disney+ Price to Jump 13% to $21.49 Per Month
22:21